Displaying drugs 14626 - 14650 of 15256 in total
BEA-17
BEA-17 is a small molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST. It is under investigation for the treatment of glioblastoma.
Investigational
Matched Description: … BEA-17 is a small molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST. …
Zandatrigine
Zandatrigine is under investigation in clinical trial NCT05226780 (Extension Study to Evaluate How Safe and Tolerable NBI-921352 Is as an Adjunctive Therapy for Participants With SCN8A-DEE).
Investigational
Matched Description: … Zandatrigine is under investigation in clinical trial NCT05226780 (Extension Study to Evaluate How Safe and …
5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone
Experimental
Metizoline
Experimental
Didesmethylrocaglamide
Didesmethylrocaglamide is a naturally-occurring derivative of rocaglamide and belongs to a class of anti-cancer phytochemicals referred to as "rocaglamides" derived from plants of the genus Aglaia. While traditionally used for their insecticidal benefits, this class of compounds is now being studied for use as chemotherapeutic agents in the treatment of...
Experimental
Matched Description: … Didesmethylrocaglamide is a naturally-occurring derivative of [rocaglamide] and belongs to a class of ... being studied for use as chemotherapeutic agents in the treatment of various leukemias, lymphomas, and …
Ravuconazole
Investigational
CRA_10991
Experimental
3h-Indole-5,6-Diol
Experimental
Xylose-derived lactam oxime
Experimental
3-Methylpyridine
Experimental
D-gluconhydroximo-1,5-lactam
Experimental
Indole
Experimental
5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole
Experimental
Carbazole
Experimental
(S)-carazolol
Experimental
1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
Experimental
Displaying drugs 14626 - 14650 of 15256 in total